科研成果详情

题名Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI
作者
发表日期2022-08-08
发表期刊FRONTIERS IN ONCOLOGY   影响因子和分区
语种英语
原始文献类型Article
关键词Glioblastoma multiforme BRAF Ring enhancement MRI Nomogram
其他关键词CENTRAL-NERVOUS-SYSTEM ; EPITHELIOID GLIOBLASTOMAS ; ADJUVANT TEMOZOLOMIDE ; CLASSIFICATION ; TUMORS ; RADIOTHERAPY ; CONCOMITANT ; DABRAFENIB ; RECURRENT ; THERAPY
摘要BackgroundRing enhancement on magnetic resonance imaging (MRI) is an important characteristic of GBM. Though patients suffering from glioblastoma multiforme (GBM) with BRAF mutation (MUT BRAF) in V600E benefit from BRAF-targeted inhibitors, the relationship between ring enhancement and MUT BRAF remains elusive. The purpose of this study was to investigate the relationship between BRAF mutation status and the appearance of ring enhancement so as to guide preoperative targeted therapy for MUT BRAF GBM. MethodsPatient's population, clinical data and characteristic ring enhancement appearances on MRI were compared between GBM with MUT BRAF and GBM with WT BRAF. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the differential diagnostic significance. A nomogram was developed to predict the mutation status of BRAF. Moreover, all the variables were re-analyzed between epithelioid GBM (E-GBM) with or without MUT BRAF. ResultsCompared to GBM with WT BRAF, GBM with MUT BRAF had specific ring enhancement appearances with multiple rings, multiple located lobes, regular shape of ring, uniform thickness of ring and smaller diameter of ring. Area under the curve (AUC) of all the variables' combination was 0.929. The nomogram was developed and validated. The re-analyzed results between E-GBM with or without MUT BRAF were similar to these above. AUC of the combination of quantity of ring, quantity of located lobe and shape of ring was 0.962. ConclusionThe characteristic ring enhancement appearances of GBM may play an important role in predicting BRAF mutation status preoperatively, especially in E-GBM. Further study with larger cases may provide more evidences to guide the pretreatment of targeted medicine for GBM patients with MUT BRAF in future.
资助项目National Natural Science Foundation of China; Shanghai Sailing Program; Research Project of Xinhua Hospital; Doctoral Research Fund of the First Affiliated Hospital of USTC; WenZhou Science and Technology Bureau Project; [81902521]; [19YF1432800]; [XH1936]; [RC2021121]; [Y20190143]
出版者FRONTIERS MEDIA SA
出版地LAUSANNE
ISSN2234-943X
卷号12页码:937345
DOI10.3389/fonc.2022.937345
页数12
WOS类目Oncology
WOS研究方向Oncology
WOS记录号WOS:000843373300001
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
Pubmed记录号36003762
Scopus记录号2-s2.0-85136479088
通讯作者地址[Chen, Ming]Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Shanghai,China ; [Li, Shiting]Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,the Cranial Nerve Disease Center of Shanghai Jiaotong University,Shanghai,China ; [Wang, Xuhui]Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Cranial Nerve Disease Center of Shanghai,Jiaotong University,Shanghai,China
scopus学科分类Oncology;Cancer Research
引用统计
被引频次[WOS]:0   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/154255
专题附属第一医院_神经外科
通讯作者Li, Shiting; Wang, Xuhui; Chen, Ming
作者单位
1.Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Shanghai,China;
2.Department of Neurosurgery,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,China;
3.Department of Neurosurgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China;
4.Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Cranial Nerve Disease Center of Shanghai,Jiaotong University,Shanghai,China;
5.Department of Neurosurgery,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Chongming Branch,Shanghai,China
推荐引用方式
GB/T 7714
Cai, Xiaomin,Chen, Zheng,Chang, Bowen,et al. Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI[J]. FRONTIERS IN ONCOLOGY,2022,12:937345.
APA Cai, Xiaomin., Chen, Zheng., Chang, Bowen., Tu, Ming., Li, Shiting., ... & Chen, Ming. (2022). Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI. FRONTIERS IN ONCOLOGY, 12, 937345.
MLA Cai, Xiaomin,et al."Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI".FRONTIERS IN ONCOLOGY 12(2022):937345.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Cai, Xiaomin]的文章
[Chen, Zheng]的文章
[Chang, Bowen]的文章
百度学术
百度学术中相似的文章
[Cai, Xiaomin]的文章
[Chen, Zheng]的文章
[Chang, Bowen]的文章
必应学术
必应学术中相似的文章
[Cai, Xiaomin]的文章
[Chen, Zheng]的文章
[Chang, Bowen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。